Author Correction: FGL2 promotes tumor progression in the CNS by suppressing CD103+ dendritic cell differentiation
The original version of this Article contained errors in the author affiliations. Qingnan Zhao, Xueqing Xia, Longfei Huo and Shulin Li were incorrectly associated with Beijing Institute for Brain Disorders, 100069, Beijing, China.This has now been corrected in both the PDF and HTML versions of the A...
Guardado en:
Autores principales: | Jun Yan, Qingnan Zhao, Konrad Gabrusiewicz, Ling-Yuan Kong, Xueqing Xia, Jian Wang, Martina Ott, Jingda Xu, R. Eric Davis, Longfei Huo, Ganesh Rao, Shao-Cong Sun, Stephanie S. Watowich, Amy B. Heimberger, Shulin Li |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/356a0bf00a73476186ba34ce68950918 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
FGL2 promotes tumor progression in the CNS by suppressing CD103+ dendritic cell differentiation
por: Jun Yan, et al.
Publicado: (2019) -
March1-dependent modulation of donor MHC II on CD103+ dendritic cells mitigates alloimmunity
por: Thiago J. Borges, et al.
Publicado: (2018) -
Acta No. 103
por: Banco Central de Chile
Publicado: (2019) -
Regulatory T cells induce polarization of pro-repair macrophages by secreting sFGL2 into the endometriotic milieu
por: Xin-Xin Hou, et al.
Publicado: (2021) -
CNS drugs
Publicado: (1994)